Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 4Leukemia 4Pain 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, B-Cell 3Lymphoma 3Hodgkin Disease 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Leukemia, Hairy Cell 2Hematologic Neoplasms 2Carcinoma in Situ 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Trigger Finger Disorder 1Small Cell Lung Carcinoma 1Sarcoma, Alveolar Soft Part 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Patient Satisfaction 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Mycophenolic Acid 3Cyclosporine 3midostaurin 2fludarabine phosphate 2Whole-Body Irradiation 2Therapeutics 2Peripheral Blood Stem Cell Transplantation 2Darbepoetin alfa 2thymoglobulin 1ibrutinib 1hydrocortisone valerate 1ferrous sulfate 1ferric gluconate 1avapritinib 1Sunitinib 1Sucrose 1Rituximab 1Oxycodone 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Methadone 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Granisetron 1Filgrastim 1Epoetin Alfa 1Enzyme-Linked Immunosorbent Assay 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Mast-Cell × Acetaminophen × Clear all
NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Stanford University

Phase 2 Completed
36 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡